Enza Lacivita

29PUBLICATIONS
47CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)AutoimmunityAutonomic nervous systemBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 09, 2026
Treatment with Ureidopropanamide Formyl Peptide Receptor 2 Agonists Attenuates Brain Changes Induced by Systemic Lipopolysaccharide Administration in Rats.

|Jul 15, 2026
Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety Profile.

|Apr 16, 2026
A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation.

|Jan 28, 2026
Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease.

Leonardo Brunetti, Fabio Francavilla, Angela Santo

|Aug 23, 2025
Design, Synthesis, and Biological Evaluation of Novel Heteroaryl, Squaramide, and Indolcarboxamide Derivatives as Formyl Peptide Receptor 2 Agonists to Target Neuroinflammation.

Fabio Francavilla, Daniele Vitone, Igor A Schepetkin

|Jul 29, 2025
Hydrogen Sulfide (H2S)-Donating Formyl Peptide Receptor 2 (FPR2) Agonists: Design, Synthesis, and Biological Evaluation in Primary Mouse Microglia Culture.

Leonardo Brunetti, Fabio Francavilla, Mauro Niso

Pageof 5

Frequent Collaborators

21 joint publications

Marcello Leopoldo

9 joint publications

Agnieszka Basta-Kaim

6 joint publications

Ewa Trojan

5 joint publications

Leonardo Brunetti